breast cancer Flashcards

(60 cards)

1
Q

Thelarche is

A

Sustained period of mammary gland growth in adolescence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breast parenchyma is composed of

A

Ducts and lobules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Breast lymphatic drainage to

A

Axillary
internal mammary lymph nodes
supraclavicular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 types of breast stroma

A

1 - intralobular - supports lobules

2 - Fibroadipose - interlobular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In young woman breast tissue is

A

very fibrous - more radiolucent with age - more adiopse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Breast examination between what structures

A

clavicle
sternum
inframammary ridge
axilla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Paget’s disease

A

In situ Brca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Non -cancerous Breast lumps can be

A

fibroadenomas

fibrocytic chances in prolfierative disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

triple test for breast cancer diag

A

1- breast exam
2- imaging
3- biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fat and dairy have
red meat
vitamin D

A

no significant impact on brca
slight impact of red meat and alcohol
vitamin D reduces risk, soy not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Linear relationship between

A

Alcohol and breast cancer
3-5 drinks a day - 1.5x increased risk
advise 1 drink a day
folate reduces risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Can dietary changes reduce risk for Brca?

A

NO evidence - except for slight benefit of VitD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Available agents to reduce risk

A

Tamoxifen -reduce opposite breast risk after brca in one breast
Raloxifene - for post menopausal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tamoxifen given as a chemopreventative can

A

Increase risk of endometrial hyperplasia after 5 years

better for women under 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Now 2011 guidelines recommend

A

against mammography and CBE (40-49)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How are most brca detected in women <45

A

Most often self-detected - encourage opportunistic breast examinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In 50-69 age group
in 40s age group
In 70s

A

there is 20-35% reduction in mortality
15% reduction in mortality
55% reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For 50-74 yr old women recommend mammography

A

Every 2 years - not 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

NEJM article states that

A

30% overdiagnosis of brca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

recommendations of NEJM articles

A

Most people recommend routine mammography -

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Screening recommendations of the canadian task force are for
for clinicians

A

Average risk women with NO breast symptoms

discuss screening for all above 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

50 yr old woman - screening recommendations

A

mammogram q2 years, annual if high risk
consider OBSP
discuss BA
Opportunistic BE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

40 yr old woman

A

consider mammogram q1-2 yrs depending on patient risk and preference
discuss bA
OBE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

70 yr old woman

A

mammography until life expectancy <10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Younger women present with what type of tumor | Cysts common
Fibroadenoma - not always - wider than it is taller | pre and peri-menopausal women
26
Mediolateral view of the breast is
Most important - covers most tissue
27
Biopsy should be consideredin BI-RADS when
4 | 0- means needs more info
28
What 4 things do you look for on screening
1- asymmetries 2- distortion 3- masses 4- calcifications
29
Breast cancer attributable to inheritance of a known mutated gene constitutes
<10% of total cases | BRCA1/2 - 50-80% lifetime risk
30
If you have pre-invasive disease -
at 10x increased risk for Brca (dcis, lcis)
31
atypical hyperplasia
proiferative disease with nuclear atypia
32
what percent of women will have fibrocystic breast changes
33% | thought to be estrogen driven
33
Proliferative breast changes without atypia include
``` florid ductal hyperplasia sclerosing adenosis papillomas preserved basal cell layer!! 1.5-2x increased risk ```
34
Proliferative breast changes WITH atypia include
ductal or lobular hyperplasias resemble cancer preserved basal cell layer! 5x risk! for both breasts!!
35
DCIS
no invasion intact myoepithelial layer can get skin/nipple changes (paget's disease)
36
paget's disease
extenstion of an insitu process
37
No special type invasive ductal carcinoma
NO myoep cel layer
38
Lobular carcinoma
lost E cadherin | indivdual cells
39
Amplification of her2/neu seen
10-30% of breast and ova cancer and poorer prognosis
40
Stage 3 and 4 tumors 5-yr survival
72% and 22%
41
which type of brca do you do a full work up - metastatic work up on
Invasive ductal carcinoma | 12% will have distant mets
42
lumpectomy - must get
radiation - 3-5 weeks - decrease local recurrence 40% recurrence just with lumpectomy 5% with radiation
43
lumpectomy with radiation compared with mastectomy
same overall survival
44
with an axillary dissection you remove
10 lymph nodes - 15% lymphedema
45
sentinal node biopsy
2-3 nodes
46
whether you have sentinal node positive and complete dissection
same recurrence!
47
30% of people with stage 1 disease develop 50% with stage 2 70% with 3 or higher
mets
48
what % of patients with her2+
20% of patients
49
hormones and traztuzumab have | chemotherapy
50% efficacy | 15-40%
50
luminal A tumors have
good prognosis c/w luminal b | high ER low prolif
51
in positive and negative node early brca - with oncotype Dx
High risk groups benefit greatly from adding chemo+hormone therapy
52
Chemo 1st gen, 2nd gen, 3rd gen
CMF
53
Tamoxifen is used
eR antagonist - used in any age group
54
aromatase inhibitors work
In the periphery, prevent androgen to estrogen conversion
55
In post-menopausal women what is the standard of care
aromatase inhibitors
56
aromatase inhibitors vs tamoxifen
no signficaint survival benefits!!
57
Tamoxifen and AI both
reduce contralateral breast cancer risk
58
Special Sideeffects of tamoxifen
increased risk of thromboembolic events | stroke and endometrial cancers
59
Side effects of AIs
increases osteoporosis risk and CVD
60
10 and 15 years after diagnosis there is a reduced risk
with taking tamoxifen continuation to 10 years